Carbon nanotubes in drug delivery: focus on infectious diseases
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Carbon nanotubes have the potential to address the challenges of combating infectious agents by both minimizing toxicity by dose reduction of standard therapeutics and allowing a multiple payload capacity to achieve both targeted activity and combating infectious strains, resistant strains in particular. One of their unique characteristics is the network of carbon atoms in the nanometer scale, allowing the creation of nano-channels via cellular membranes. This review focuses on the characterization, development, integration and application of carbon nanotubes as nanocarrier-based delivery systems and their appropriate design for achieving the desired drug delivery results in the different areas of infectious diseases. While a more extensive toxicological and pharmacological profile must be obtained, this review will focus on existing research and pre-clinical data concerning the potential use of carbon nanotubes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A. H., Seaton, A., Stone, V., Brown, S., MacNee, W., & Donaldson, K. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.111 · Cited by 2,645 · cited 1×
“suggest that scrutiny is needed before introducing CNTs to the market [114].”
BackgroundRespiratory toxicity of multi-wall carbon nanotubes
Muller, J., Huaux, F., Moreau, N., Misson, P., Heilier, J.-F., Delos, M., Arras, M., Fonseca, A., Nagy, J. B., & Lison, D. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.008 · Cited by 1,123
Oops they did it again! Carbon nanotubes hoax scientists in viability assays
Wörle-Knirsch, J. M., Pulskamp, K., & Krug, H. F. (2006) · Nano Letters · doi:10.1021/nl060177c · Cited by 994 · cited 2×
“It should be noted that the results of cytotoxicity of CNTs can be contradictory to efficacy, as functionalization and differing purities can affect the toxicity [70-78].”
BackgroundResistance in bacteria of the food chain: Epidemiology and control strategies
Aarestrup, F. M., Wegener, H. C., & Collignon, P. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.733 · Cited by 406
Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors
Bokhoven, M., Stephen, S. L., Knight, S., Gevers, E. F., Robinson, I. C., Takeuchi, Y., & Collins, M. K. (2009) · Journal of Virology · doi:10.1128/jvi.01865-08 · Cited by 138 · cited 2×
“Viral delivery, albeit achieving high levels of gene expression, has several noteworthy disadvantages such as induction of immunogenic reactions, induction of inflammatory reactions which render transient transgene expression and potential oncogenic effects [31,32,82,83].”
Background
Cited by
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
Carbon Nanotubes: Applications in Pharmacy and Medicine
He, H., Pham-Huy, L. A., Dramou, P., Xiao, D., Zuo, P., & Pham-Huy, C. (2013) · BioMed Research International · doi:10.1155/2013/578290 · Cited by 533
Algar, W. R., Prasuhn, D. E., Stewart, M. H., Jennings, T. L., Blanco-Canosa, J. B., Dawson, P. E., & Medintz, I. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200065z · Cited by 502
Advancement in carbon nanotubes: basics, biomedical applications and toxicity
Beg, S., Rizwan, M., Sheikh, A. M., Hasnain, M. S., Anwer, K., & Kohli, K. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01167.x · Cited by 306
Toxicity of Carbon Nanotubes as Anti-Tumor Drug Carriers
Yan, H., Xue, Z., Xie, J., Dong, Y., Ma, Z., Sun, X., Kebebe Borga, D., Liu, Z., & Li, J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s220087 · Cited by 113
Metadata
- Authors
- Rosen, Y., & Elman, N. M.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2009-05
- Volume
- 6
- Issue
- 5
- Pages
- 517-530
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2080219726
- Cited by
- 69
- References
- 5
- FWCI
- 2.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carbon nanotubes in drug delivery: focus on infectious diseases. https://app.cochat.ai/papers/10.1517/17425240902865579
- The paper
- Rosen, Y., & Elman, N. M. (2009). Carbon nanotubes in drug delivery: focus on infectious diseases. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425240902865579
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.